published meta-analysis   sensitivity analysis   studies

anticoagulant, prophylactic dose in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsGonzalez-Porras, 2020 1.44 [1.08; 1.92] Trinh, 2020 1.72 [1.39; 2.13] 1.61[1.36; 1.92]Gonzalez-Porras, 2020, Trinh, 202020%NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-07-02 19:12 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 829 - roots T: 290